Proportion of isolates with decreased susceptibility or resistance in Slovakia
Slovakia: Proportion of isolates with decreased susceptibility or resistance was 0 in 2018. ◆ Volatile
Proportion of isolates with decreased susceptibility or resistance in Slovakia, 2009–2018
Source: World Health Organization, Global Health Observatory.
Analysis
The most recent figure for proportion of isolates with decreased susceptibility or resistance in Slovakia is 0, measured in 2018. That is the lowest value across all 10 years on record.
That represents a change of down 100.0% over five years.
Over the whole period, proportion of isolates with decreased susceptibility or resistance in Slovakia peaked at 36.28 in 2011 and was at its lowest, 0, in 2009.
Slovakia ranks 15th of 27 countries on this measure, in the middle of the range.
The series is highly variable year to year, so single readings are best treated with caution.
Proportion of isolates with decreased susceptibility or resistance in Slovakia, year by year
| Year | Value | Change |
|---|---|---|
| 2009 | 0 | — |
| 2010 | 14.77 | — |
| 2011 | 36.28 | +145.6% |
| 2012 | 3.7 | -89.8% |
| 2013 | 4.55 | +22.7% |
| 2014 | 0.9174 | -79.8% |
| 2015 | 3.85 | +319.2% |
| 2016 | 3.64 | -5.5% |
| 2017 | 0 | -100.0% |
| 2018 | 0 | — |
Slovakia compared with similar countries
- Slovakia's 0 is below the median for Europe & Central Asia, which is 1. (23 countries reporting)
- Slovakia's 0 is below the median for high income countries, which is 0.2907. (25 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2000s | 0 | 0 | 0 | 1 |
| 2010s | 7.52 | 0 | 36.28 | 9 |
Countries ranked near Slovakia
- 12 Germany 1 compare
- 13 Canada 0.5445 compare
- 14 United States of America 0.2907 compare
- 15 Estonia 0
- 15 Malta 0 compare
- 15 France 0 compare
- 15 Netherlands 0 compare
- 15 Slovenia 0 compare
- 15 Iceland 0
- 15 Latvia 0 compare
- 15 Portugal 0 compare
- 15 Ireland 0 compare
- 15 Norway 0 compare
- 15 Côte d'Ivoire 0
- 15 Denmark 0 compare
More health data for Slovakia
- Un projection of annual infant deaths, annual growth rate 0 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate -0.9332 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,433 deaths per 1,000 people (2090)
- Number of infants who die before age 1 28 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -3.48 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0234 units per person (2025)
- Population ages 00-04, male, annual growth rate -3.33 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is proportion of isolates with decreased susceptibility or resistance in Slovakia?
- Proportion of isolates with decreased susceptibility or resistance in Slovakia was 0 in 2018, according to World Health Organization, Global Health Observatory.
- What is the highest proportion of isolates with decreased susceptibility or resistance recorded in Slovakia?
- The highest recorded value was 36.28 in 2011.
- What is the lowest proportion of isolates with decreased susceptibility or resistance recorded in Slovakia?
- The lowest recorded value was 0 in 2009.
- How does Slovakia rank for proportion of isolates with decreased susceptibility or resistance?
- Slovakia ranks 15th out of 27 countries with data for 2018.
- Where does this Slovakia data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of Proportion of isolates with decreased susceptibility or resistance (DS/R) to cefixime reported to WHO-GASP. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 10 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).